Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function

Detalhes bibliográficos
Autor(a) principal: Fonseca, Lara R. S.
Data de Publicação: 2021
Outros Autores: Silva, Gonçalo R., Luís, Ângelo, Cardoso, Henrique J., Correia, Sara, Vaz, CV, Duarte, Ana Paula, Socorro, Sílvia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/11243
Resumo: Sweet cherries (Prunus avium L.) are among the most appreciated fruits worldwide because of their organoleptic properties and nutritional value. The accurate phytochemical composition and nutritional value of sweet cherries depends on the climatic region, cultivar, and bioaccessibility and bioavailability of specific compounds. Nevertheless, sweet cherry extracts are highly enriched in several phenolic compounds with relevant bioactivity. Over the years, technological advances in chemical analysis and fields as varied as proteomics, genomics and bioinformatics, have allowed the detailed characterization of the sweet cherry bioactive phytonutrients and their biological function. In this context, the effect of sweet cherries on suppressing important events in the carcinogenic process, such as oxidative stress and inflammation, was widely documented. Interestingly, results from our research group and others have widened the action of sweet cherries to many hallmarks of cancer, namely metabolic reprogramming. The present review discusses the anticarcinogenic potential of sweet cherries by addressing their phytochemical composition, the bioaccessibility and bioavailability of specific bioactive compounds, and the existing knowledge concerning the effects against oxidative stress, chronic inflammation, deregulated cell proliferation and apoptosis, invasion and metastization, and metabolic alterations. Globally, this review highlights the prospective use of sweet cherries as a dietary supplement or in cancer treatment.
id RCAP_e85b30ebd1792e61f490d51f0c8c89ce
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/11243
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to FunctionSweet cherriesAnthocyaninsAnti-cancer agentsOxidative stressInflammationProliferationApoptosisInvasionMetastizationMetabolic reprogrammingSweet cherries (Prunus avium L.) are among the most appreciated fruits worldwide because of their organoleptic properties and nutritional value. The accurate phytochemical composition and nutritional value of sweet cherries depends on the climatic region, cultivar, and bioaccessibility and bioavailability of specific compounds. Nevertheless, sweet cherry extracts are highly enriched in several phenolic compounds with relevant bioactivity. Over the years, technological advances in chemical analysis and fields as varied as proteomics, genomics and bioinformatics, have allowed the detailed characterization of the sweet cherry bioactive phytonutrients and their biological function. In this context, the effect of sweet cherries on suppressing important events in the carcinogenic process, such as oxidative stress and inflammation, was widely documented. Interestingly, results from our research group and others have widened the action of sweet cherries to many hallmarks of cancer, namely metabolic reprogramming. The present review discusses the anticarcinogenic potential of sweet cherries by addressing their phytochemical composition, the bioaccessibility and bioavailability of specific bioactive compounds, and the existing knowledge concerning the effects against oxidative stress, chronic inflammation, deregulated cell proliferation and apoptosis, invasion and metastization, and metabolic alterations. Globally, this review highlights the prospective use of sweet cherries as a dietary supplement or in cancer treatment.uBibliorumFonseca, Lara R. S.Silva, Gonçalo R.Luís, ÂngeloCardoso, Henrique J.Correia, SaraVaz, CVDuarte, Ana PaulaSocorro, Sílvia2021-11-08T09:58:34Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.6/11243eng10.3390/molecules26102941info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:53:40Zoai:ubibliorum.ubi.pt:10400.6/11243Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:51:05.313245Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
title Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
spellingShingle Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
Fonseca, Lara R. S.
Sweet cherries
Anthocyanins
Anti-cancer agents
Oxidative stress
Inflammation
Proliferation
Apoptosis
Invasion
Metastization
Metabolic reprogramming
title_short Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
title_full Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
title_fullStr Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
title_full_unstemmed Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
title_sort Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function
author Fonseca, Lara R. S.
author_facet Fonseca, Lara R. S.
Silva, Gonçalo R.
Luís, Ângelo
Cardoso, Henrique J.
Correia, Sara
Vaz, CV
Duarte, Ana Paula
Socorro, Sílvia
author_role author
author2 Silva, Gonçalo R.
Luís, Ângelo
Cardoso, Henrique J.
Correia, Sara
Vaz, CV
Duarte, Ana Paula
Socorro, Sílvia
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv uBibliorum
dc.contributor.author.fl_str_mv Fonseca, Lara R. S.
Silva, Gonçalo R.
Luís, Ângelo
Cardoso, Henrique J.
Correia, Sara
Vaz, CV
Duarte, Ana Paula
Socorro, Sílvia
dc.subject.por.fl_str_mv Sweet cherries
Anthocyanins
Anti-cancer agents
Oxidative stress
Inflammation
Proliferation
Apoptosis
Invasion
Metastization
Metabolic reprogramming
topic Sweet cherries
Anthocyanins
Anti-cancer agents
Oxidative stress
Inflammation
Proliferation
Apoptosis
Invasion
Metastization
Metabolic reprogramming
description Sweet cherries (Prunus avium L.) are among the most appreciated fruits worldwide because of their organoleptic properties and nutritional value. The accurate phytochemical composition and nutritional value of sweet cherries depends on the climatic region, cultivar, and bioaccessibility and bioavailability of specific compounds. Nevertheless, sweet cherry extracts are highly enriched in several phenolic compounds with relevant bioactivity. Over the years, technological advances in chemical analysis and fields as varied as proteomics, genomics and bioinformatics, have allowed the detailed characterization of the sweet cherry bioactive phytonutrients and their biological function. In this context, the effect of sweet cherries on suppressing important events in the carcinogenic process, such as oxidative stress and inflammation, was widely documented. Interestingly, results from our research group and others have widened the action of sweet cherries to many hallmarks of cancer, namely metabolic reprogramming. The present review discusses the anticarcinogenic potential of sweet cherries by addressing their phytochemical composition, the bioaccessibility and bioavailability of specific bioactive compounds, and the existing knowledge concerning the effects against oxidative stress, chronic inflammation, deregulated cell proliferation and apoptosis, invasion and metastization, and metabolic alterations. Globally, this review highlights the prospective use of sweet cherries as a dietary supplement or in cancer treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-08T09:58:34Z
2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/11243
url http://hdl.handle.net/10400.6/11243
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.3390/molecules26102941
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136400530997248